{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:36:07Z","timestamp":1793817367557,"version":"4.6.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T00:00:00Z","timestamp":1530748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1093\/infdis\/jiy391","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T15:13:15Z","timestamp":1529939595000},"page":"10-18","source":"Crossref","is-referenced-by-count":96,"title":["Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir\u2014A Propensity Score\u2013Matched Study"],"prefix":"10.1093","volume":"219","author":[{"given":"Mindie H","family":"Nguyen","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwai-I","family":"Yang","sequence":"additional","affiliation":[{"name":"Genomics Research Center, Academia Sinica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Le","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Henry","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nghia","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Hsuan","family":"Lee","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan, Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Chinese Hospital, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Wong","sequence":"additional","affiliation":[{"name":"Wong Clinics, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford","family":"Wong","sequence":"additional","affiliation":[{"name":"Wong Clinics, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy","family":"Trinh","sequence":"additional","affiliation":[{"name":"San Jose Gastroenterology, San Jose, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,5]]},"reference":[{"key":"key\n\t\t\t\t2018120710240990000_CIT0001","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0002","first-page":"1","article-title":"Recommendations for identification and public health management of persons with chronic hepatitis B virus infection","volume":"57","author":"Weinbaum","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0003","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.24804","article-title":"Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin","volume":"56","author":"Kowdley","year":"2012","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0004","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/apt.13774","article-title":"Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients","volume":"44","author":"Lin","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0005","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/2012.jama.11975","article-title":"Association between nucleoside analogues and risk of hepatitis B virus\u2013related hepatocellular carcinoma recurrence following liver resection","volume":"308","author":"Wu","year":"2012","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0006","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"Electronic address eee, European Association for the Study of the L. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0007","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0008","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.cgh.2015.07.007","article-title":"A treatment algorithm for the Management of chronic hepatitis B virus infection in the United States: 2015 update","volume":"13","author":"Martin","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0009","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12072-012-9365-4","article-title":"Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update","volume":"6","author":"Liaw","year":"2012","journal-title":"Hepatol Int"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0010","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jhep.2010.02.035","article-title":"Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review","volume":"53","author":"Papatheodoridis","year":"2010","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0011","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000082092","article-title":"Hepatitis B virus-related hepatocellular carcinogenesis and its prevention","volume":"48","author":"Ikeda","year":"2005","journal-title":"Intervirology"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0012","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1440-1746.2009.06161.x","article-title":"Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patients","volume":"25","author":"Suzuki","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0013","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jhep.2014.08.045","article-title":"Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir","volume":"62","author":"Papatheodoridis","year":"2015","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0014","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/jvh.12358","article-title":"Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-na\u00efve chronic hepatitis B patients in the real-world setting","volume":"22","author":"Idilman","year":"2015","journal-title":"J Viral Hepat"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0015","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.bpg.2008.11.003","article-title":"Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success","volume":"22","author":"Chien","year":"2008","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0016","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1053\/j.gastro.2013.12.028","article-title":"Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B","volume":"146","author":"Fung","year":"2014","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0017","doi-asserted-by":"crossref","first-page":"e0130392","DOI":"10.1371\/journal.pone.0130392","article-title":"Comparison of the efficacy of entecavir and tenofovir in nucleos(T)ide analogue-experienced chronic hepatitis B patients","volume":"10","author":"Cho","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0018","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/j.gastro.2012.05.037","article-title":"Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naive patients with chronic hepatitis B","volume":"143","author":"Lok","year":"2012","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0019","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/apt.12629","article-title":"Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA","volume":"39","author":"Gao","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0020","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1002\/cncr.29537","article-title":"Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B","volume":"121","author":"Kim","year":"2015","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0021","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1470-2045(11)70077-8","article-title":"Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score","volume":"12","author":"Yang","year":"2011","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0022","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cld.2007.08.005","article-title":"Long-term outcomes in hepatitis B: the REVEAL-HBV study","volume":"11","author":"Chen","year":"2007","journal-title":"Clin Liver Dis"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0023","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/hep.28280","article-title":"Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis","volume":"63","author":"Lok","year":"2016","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0024","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/00031305.1985.10479383","article-title":"Constructing a control-group using multivariate matched sampling methods that incorporate the propensity score","volume":"39","author":"Rosenbaum","year":"1985","journal-title":"Am Stat"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12072-015-9614-4","article-title":"Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years","volume":"9","author":"Buti","year":"2015","journal-title":"Hepatol Int"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0026","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep.26301","article-title":"Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis","volume":"58","author":"Wong","year":"2013","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0027","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.26180","article-title":"Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection","volume":"58","author":"Hosaka","year":"2013","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0028","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","article-title":"Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy","volume":"62","author":"Papatheodoridis","year":"2015","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0029","article-title":"Annual report to the nation on the status of cancer, 1975\u20132014, featuring survival","volume":"109","author":"Jemal","year":"2017","journal-title":"J Natl Cancer Ist"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0030","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.27222","article-title":"Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go","volume":"60","author":"El-Serag","year":"2014","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2018120710240990000_CIT0031","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.3748\/wjg.v21.i18.5524","article-title":"Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B","volume":"21","author":"Pan","year":"2015","journal-title":"World J Gastroenterol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/219\/1\/10\/27053692\/jiy391.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T14:27:18Z","timestamp":1720362438000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/219\/1\/10\/5049301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,5]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,7,5]]},"published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy391","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1,1]]},"published":{"date-parts":[[2018,7,5]]}}}